DVx Inc.

Equities

3079

JP3548710007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
996 ^JPY	-0.50%		-0.30%	-6.39%

2023	INTERVIEW - Jon McNeill , ex-president of TESLA: Tesla's charging standards must become the industry standard	MT
2022	General Motors Says Former Tesla, Lyft Executive Jonathan McNeill Joins Board	MT

Tranche Update on DVx Inc.'s Equity Buyback Plan announced on August 28, 2018.

August 28, 2018 at 09:30 pm EDT

From August 28, 2018 to August 29, 2018, the company has repurchased 450,000 shares, representing 3.99% for ¥623.7 million. With this, the company has completed the repurchase of 450,000 shares, representing 3.99% for ¥623.7 million under the buyback announced on August 28, 2018.

Latest news about DVx Inc.

INTERVIEW - Jon McNeill , ex-president of TESLA: Tesla's charging standards must become the industry standard	23-06-12	MT
General Motors Says Former Tesla, Lyft Executive Jonathan McNeill Joins Board	22-10-04	MT
Former Tesla executive joins board of rival automaker GM	22-10-04	RE
ICorNet Research Institute Inc. announced that it has received funding from DVx Inc.	21-01-28	CI
Tranche Update on DVx Inc.'s Equity Buyback Plan announced on August 14, 2019.	19-08-14	CI
DVx Inc.'s Equity Buyback announced on August 14, 2019 has closed with 550,000 shares, representing 5.08% for ¥431.75 million.	19-08-14	CI
DVx Inc. announces an Equity Buyback for 550,000 shares, representing 5.08% for ¥431.75 million.	19-08-14	CI
DVx Inc. authorizes a Buyback Plan.	19-08-13	CI
Dvx Inc. Reports Unaudited Non-Consolidated Financial Results for the Three Months Ended June 30, 2019; Provides Non-Consolidated Financial Guidance for the Six Months Ended September 30, 2019 and Full Year Ending March 31, 2020; Provides Dividend Guidance for the Year Ended March 31, 2020	19-07-29	CI
Tranche Update on DVx Inc.'s Equity Buyback Plan announced on August 28, 2018.	18-08-28	CI
DVx Inc.'s Equity Buyback announced on August 28, 2018 has closed with 450,000 shares for ¥623.7 million.	18-08-28	CI
DVx Inc. announces an Equity Buyback for 450,000 shares, representing 3.99% for ¥623.7 million.	18-08-28	CI
DVx Inc. authorizes a Buyback Plan.	18-08-27	CI
DVx Inc. Reports Unaudited Non-Consolidated Financial Results for the Year Ended March 31, 2018; Provides Non-Consolidated Financial Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019	18-05-14	CI
DVx Inc. Announces Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018	18-02-01	CI
DVx Inc. Reports Non-Consolidated Financial Results for the First Six Months Ended Sep. 30, 2017; Provides Financial and Dividend Guidance for the Year Ending Mar. 31, 2018	17-10-30	CI
DVx Inc. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Six Months Ending September 30, 2017; Provides Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Full Year Ending March 31, 2018	17-07-31	CI
DVx Inc. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Non-Consolidated Earnings Guidance for the First Half and Full Year of Fiscal 2018; Announces Year-End Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Year-End Dividend Guidance for the Year Ending March 31, 2018	17-05-14	CI
DVx Inc. Announces Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2016; Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2017; Provides Dividend Guidance for the Year Ending March 31, 2017	17-02-01	CI
DVx Inc. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Non-Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending March 31, 2017; Expects to Pay Year-End Dividend for the Fiscal Year Ending March 31, 2017	16-10-31	CI
DVx Inc. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Six Months Ending September 30, 2016; Provides Earnings Guidance for the Full Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017	16-07-31	CI
DVx Inc. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2016; Provides Non-Consolidated Earnings Guidance for the First Half Ending September 30, 2016 and Full Year Ending March 31, 2017	16-05-12	CI
DVx Inc. Provides Dividend Guidance for the Year Ended March 31, 2016; Reports Earnings Results for the Third Quarter Ended December 31, 2015; Provides Earnings Guidance for the year Ending of March 31, 2016	16-02-03	CI
DVx Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2015; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2016; Provides Earnings Forecast for the Fiscal Year Ending March 31, 2016	15-11-02	CI
DVx Inc. Reports Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for Six Months Ending September 30, 2015 and Year Ending March 31, 2016	15-08-13	CI

Chart DVx Inc.

Duration

Period

More charts

Company Profile

DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - Q4 2023 Earnings Release

More about the company

	1st Jan change	Capi.
DVX INC.	-6.39%	62.02M
HENRY SCHEIN, INC.	-3.41%	9.4B
SHIP HEALTHCARE HOLDINGS, INC.	-3.90%	1.39B
AS ONE CORPORATION	-7.38%	1.18B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-18.42%	856M
TOKAI CORP.	+0.48%	470M
EXCELSIOR MEDICAL CO., LTD.	+3.62%	437M
GAUSH MEDITECH LTD	-49.68%	360M
COWEALTH MEDICAL CHINA CO.,LTD.	-24.72%	333M
WIN-PARTNERS CO., LTD.	-2.42%	212M

Medical Equipment Wholesale

DVx Inc.

Equities

3079

JP3548710007

Medical Equipment, Supplies & Distribution

Tranche Update on DVx Inc.'s Equity Buyback Plan announced on August 28, 2018.

Latest news about DVx Inc.

Chart DVx Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Medical Equipment Wholesale